This article summarizes the clinical experience with the new, orally a
ctive iron chelator, deferiprone, for transfusional iron-loaded patien
ts with thalassemia and other refractory anemias. In addition, it revi
ews novel uses of iron chelation and potential new applications in acu
te iron poisoning.